By Anna Tsioulias
Antimicrobial resistance of Neisseria gonorrhoeae is a significant threat against efforts to treat and control gonorrhea. According to the CDC, rates of the disease have increased more than 11% in five years, with cases increase from 583,405 in 2018 to 648,056 in 2022.
The CDC has classified drug-resistant gonorrhea as an urgent threat because it has rapidly developed resistance to all but one class of antibiotics with roughly 50% of all infections are